The following is a summary of “Brain tissue integrity in neuromyelitis optica spectrum disorder through T1-w/T2-w ratio, MTR ...

Objective To describe onset clinical features predicting time to first relapse and time to long-term visual, motor and cognitive disabilities in paediatric-onset aquaporin-4 antibody (AQP4-IgG) ...

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and neuromyelitis optica spectrum disorders (NMOSD) are two rare autoimmune inflammatory demyelinating diseases involving the ...

LPXTI-641 is under clinical development by Lapix Therapeutics and currently in Phase I for Neuromyelitis Optica (Devic’s Syndrome). According to GlobalData, Phase I drugs for Neuromyelitis Optica ...

After an astonishing career in beauty rethinking how makeup is sold, Victoria Jackson is back with a new brand, No Makeup ...

There are a wide variety of neurological diseases affecting the brain and nervous system. Understanding the specifics can help you navigate diagnostic tests and choose the best course of treatment.

TDP43 seems to worsen the inflammatory activation of astrocytes in neuromyelitis optica spectrum disorder (NMOSD), a study found.

Immunotherapy treatment was effective at reducing attack recurrence in patients with NMOSD but was less effective for MOGAD, a study found.

Importance Chronic, intractable neuropathic pain is a common and debilitating consequence of neuromyelitis optica spectrum disorder (NMOSD) myelitis, with no satisfactory treatment; few studies have ...

ECTRIMS and EBMT said stem cell transplant can be considered for some with RRMS, such as those who are younger and have less ...